A PD-L1 cross-link of tumor cells with T-lymphocytes expressing PD-1 leads to T-cell anergy, as well as the promotion and activation of regulatory T cells (Tregs) and allows tumor cells to evade the host immune system and inhibit the immune response. This evidence concerns the gene PDCD1 and neoplasm.